Cargando…

Novel MDR-reversing inhibitors of MRP subtypes related to antiretroviral drug resistance and CD4 cell counts

Detalles Bibliográficos
Autores principales:	Hilgeroth, Andreas, Naujoks, Paul, Neuber, Sebastian, Hemmer, Marc, Lage, Hermann, Molnar, Joséf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221012/ http://dx.doi.org/10.1186/1471-2334-14-S2-P77

Ejemplares similares

Antiretroviral treatment and expression of the mRNA levels for Pgp, MRP1, MRP4 and MRP5 in HIV antiretroviral naïve patients. Follow-up at 48 weeks
por: Falasca, Francesca, et al.
Publicado: (2010)

Cytotoxicity and reversal effect of sertraline, fluoxetine, and citalopram on MRP1- and MRP7-mediated MDR
por: Bin Kanner, Yuval, et al.
Publicado: (2023)

Absolute lymphocyte count as a marker for CD4 lymphocyte count: criterion for initiating antiretroviral therapy in HIV-infected Nigerians
por: Erhabor, Osaro, et al.
Publicado: (2009)

The TLR4 ligands MRP8 and MRP14 in the diagnosis and pathogenesis of systemic onset juvenile idiopathic arthritis
por: Frosch, M, et al.
Publicado: (2008)

Changing antiretrovirals whilst viral load <50 copies/ml and relationship with CD4 count changes
por: Mocroft, A
Publicado: (2010)

PD173074, a selective FGFR inhibitor, reverses MRP7 (ABCC10)-mediated MDR
por: Anreddy, Nagaraju, et al.
Publicado: (2014)

The effects of highly active antiretroviral therapy (HAART) of stavudine, lamivudine and nevirapine on the CD4 lymphocyte count of HIV-infected Africans: the Nigerian experience
por: Erhabor, Osaro, et al.
Publicado: (2009)

Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport
por: Evers, R, et al.
Publicado: (2000)

Comparative study on use of CD4 T cell count and plasma P24 antigen concentration in antiretroviral therapy monitoring for HIV/AIDs patients in Kano, Nigeria
por: Yahaya, Abdulrazak, et al.
Publicado: (2006)

Reversing Multidrug Resistance in Caco-2 by Silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL Using Liposomal Antisense Oligonucleotides
por: Lo, Yu-Li, et al.
Publicado: (2014)

T-CD4+ cell count at the date of the HIV diagnosis
por: Domingues da Silva, AR, et al.
Publicado: (2010)

Source of MDR infections in an ICU: busting the myth
por: Agrawal, R
Publicado: (2015)

Correction: Reversing Multidrug Resistance in Caco-2 by Silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL Using Liposomal Antisense Oligonucleotides
Publicado: (2014)

The endogenous TLR-4 ligands MRP8/14 as biomarkers of inflammation in Familial Mediterranean Fever (FMF)
por: Wittkowski, H, et al.
Publicado: (2008)

Novel Nonsymmetrical 1,4-Dihydropyridines as Inhibitors of Nonsymmetrical MRP-Efflux Pumps for Anticancer Therapy
por: Kreutzer, David, et al.
Publicado: (2020)

Sudden unexplained death in a patient with HIV and MDR-TB
por: Boxall, E, et al.
Publicado: (2010)

Rapid speciation of mycobacteria with simultaneous detection of MDR tB
por: Kakati, Barnali, et al.
Publicado: (2014)

Primary and secondary bacteremia caused by mdr bacteria in ICU patients
por: Pappa, E, et al.
Publicado: (2015)

Comparative evaluation by semiquantitative reverse transcriptase polymerase chain reaction of MDR1, MRP and GSTp gene expression in breast carcinomas.
por: Lacave, R., et al.
Publicado: (1998)

Efficacy and safety of lopinavir/ritonavir (LPV/r) in antiretroviral-experienced subjects infected with different subtypes of HIV-1
por: Maroldo, L, et al.
Publicado: (2010)

New diagnostic marker for sepsis: soluble CD14 subtype
por: Shirakawa, K, et al.
Publicado: (2004)

PReS-FINAL-2145: MRP8/14 serum complexes as predictor of response to etanercept treatment in juvenile idiopathic arthritis
por: Anink, J, et al.
Publicado: (2013)

Human T cell lymphotropic virus type 1 (HTLV-1) infection increases the CD4 count in human immunodeficiency virus type 1 (HIV-1) infected patients submitted to antiretroviral therapy (ARV)
por: Rego, Filipe FA, et al.
Publicado: (2014)

Antiretroviral compounds affect the granule-dependent mechanisms of lysis in CD8 T cells
por: Parmigiani, Anita, et al.
Publicado: (2006)

Defining severe community-acquired pneumonia: a significant barrier to improving patient outcomes
por: Balp, MM, et al.
Publicado: (2009)

Myeloid related proteins 8 and 14 (mrp 8/14) - potential biomarkers of disease activity of arthritis in children with trisomy 21
por: Foley, Charlene, et al.
Publicado: (2014)

A reverse genetic screen for genes involved in ciliary formation and function
por: Moore, D, et al.
Publicado: (2012)

MRP1 but Not MDR1 Is Associated with Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
por: Taheri, Mohsen, et al.
Publicado: (2013)

MDR-1 and MRP-1 activity in peripheral blood leukocytes of rheumatoid arthritis patients
por: Micsik, Tamás, et al.
Publicado: (2015)

Assessment of the usefulness of presepsin (soluble CD14 subtype) in septic patients
por: Nishida, T, et al.
Publicado: (2012)

Assessment of the usefulness of presepsin (soluble CD14 subtype) in septic patients
por: Nishida, T, et al.
Publicado: (2011)

Evaluation of a soluble CD14 subtype in patients with surgical sepsis
por: Fukui, Y
Publicado: (2012)

Differential CD30 expression in adult T-cell leukemia-lymphoma subtypes
por: Campuzano-Zuluaga, Germán, et al.
Publicado: (2014)

Effect of range of spread of CD4 count and RNA level on the efficacy of HIV treatments
por: Towfic, George, et al.
Publicado: (2010)

Correlation between oxidative stress indices and CD4 counts in HIV infected patients
por: Annam, Vamseedhar, et al.
Publicado: (2012)

Novel Symmetrical Cage Compounds as Inhibitors of the Symmetrical MRP4-Efflux Pump for Anticancer Therapy
por: Kreutzer, David, et al.
Publicado: (2021)

Effect of Antiretroviral Therapy (ART) on HIV-1 & 2 (Subtype C) infection and its relationships to cognitive function and quality of life
por: Kumarpillai, Gopukumar, et al.
Publicado: (2010)

Analysis of transmitted drug resistance, resistance mutations and future antiretroviral efficacy in HIV-1 subtype F infected-patients prior to therapy
por: Manolescu, LSC, et al.
Publicado: (2010)

PMTCT of HIV-1 in Burkina Faso: evaluation of residual vertical transmission by PCR, molecular characterization of subtypes and determination of antiretroviral drugs resistance
por: Sagna, T, et al.
Publicado: (2014)

Risk of acquiring drug-resistant (MDR) Gram-negative isolates with previous exposure to antibiotic
por: Bhakta, A, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_rgo178lodl58jbthbv4hv3hg62